---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-22-000009"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:38:15.417751+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific EVP David Pierce to retire; Butcher and Jones to assume new roles

## Summary
- David A. Pierce, EVP and president MedSurg & Endoscopy, retiring effective July 4, 2022.
- Arthur C. Butcher becomes EVP and group president MedSurg & Asia Pacific effective May 2, 2022.
- Michael Jones becomes SVP and president Endoscopy effective May 2, 2022.
- Pierce joined in 1991 and will lead transition of responsibilities until retirement.

## SEC filing metadata
- accession: 0000885725-22-000009
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/0000885725-22-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/bsx-20220330.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-22-000009
- JSON: https://secwatch.observer/filing/0000885725-22-000009.json
- Plain text: https://secwatch.observer/filing/0000885725-22-000009.txt

## Key facts
- Executive change
  David A. Pierce departed as executive vice president and president, MedSurg and president, Endoscopy at BOSTON SCIENTIFIC CORP.
  - Action: retire
  - Role: executive vice president and president, MedSurg and president, Endoscopy
  source text: On March 30, 2022, David A. Pierce, executive vice president and president, MedSurg and president, Endoscopy, informed Boston Scientific Corporation (“Boston Scientific” or the “Company”), that he will retire, effective July 4, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/0000885725-22-000009-index.htm
- Executive change
  Arthur C. Butcher changed role as executive vice president and group president, MedSurg and Asia Pacific at BOSTON SCIENTIFIC CORP.
  - Action: change roles
  - Role: executive vice president and group president, MedSurg and Asia Pacific
  source text: Arthur C. Butcher, currently executive vice president and president, Asia Pacific, will change roles and serve as executive vice president and group president, MedSurg and Asia Pacific
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/0000885725-22-000009-index.htm
- Executive change
  Michael Jones changed role as senior vice president and president, Endoscopy at BOSTON SCIENTIFIC CORP.
  - Action: change roles
  - Role: senior vice president and president, Endoscopy
  source text: Michael Jones, currently senior vice president and general manager, Endoscopy, will change roles and serve as senior vice president and president, Endoscopy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/0000885725-22-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.